by John Conrad | Sep 11, 2024 | NewsBrief
In a significant development for the healthcare industry, Chicago-based 32 Biosciences has announced its emergence from stealth mode, unveiling a groundbreaking approach to gut microbiome medicine. The company, whose name is pronounced “Three Squared...
by John Conrad | Aug 5, 2024 | NewsBrief
COUR Pharmaceuticals, a clinical-stage biotech company focused on developing treatments for autoimmune and inflammatory diseases, has announced a significant leadership transition. Founder John J. Puisis will step down as President and Chief Executive Officer, handing...
by John Conrad | Aug 1, 2024 | NewsBrief
In a significant move to boost scientific innovation and commercialization, Portal Innovations is partnering with the University of Chicago’s Polsky Center for Entrepreneurship and Innovation to create a new science startup incubator. The collaboration will see...
by John Conrad | Jul 29, 2024 | iBIO in the News
GEN Releases 2024 Top Biopharma Clusters: Chicago Climbs to 9th Place Genetic Engineering & Biotechnology News (GEN) has unveiled its annual list of top biopharma clusters for 2024, with Chicago making a notable ascent in the rankings. The Windy City has moved up...
by John Conrad | Jul 25, 2024 | iBIO in the News
Heart failure tech developer Endotronix is being acquired by Edwards Lifesciences a month after receiving regulatory approval for its implantable pulmonary artery sensor. Irvine, Calif.-based Edwards said in a press release it was exercising its option to acquire...
